Five things for pharma marketers to know: Wednesday, October 4, 2017

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

from Most popular articles from Medical Marketing and Media http://ift.tt/2gbMxnU